BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 3, 2020
View Archived Issues
CTA cleared in China to initiate phase IIa study of infigratinib in gastric cancer
Read More
Enrollment ongoing in phase III study of marzeptacog alfa
Read More
Amgen initiates phase III study of ABP-654 in moderate to severe plaque psoriasis
Read More
Braeburn receives complete response letter for Brixadi in the U.S.
Read More
First patient dosed in phase III ASPEN study of brensocatib in bronchiectasis
Read More
Cel-Sci reports preclinical data on LEAPS COV-19 peptides
Read More
Arcutis presents data from long-term safety study of ARQ-151 in plaque psoriasis
Read More
Biotest presents compositions comprising recombinant factor VIII protein
Read More
EPA/DHA does not show benefit in patients with cardiovascular risk
Read More
Royal Melbourne Institute of Technology describes new gold complexes
Read More
Bacainn completes first-in-human study BT-051
Read More
New inhibitors of autophagy identified at Deciphera Pharmaceuticals
Read More
New THR-beta agonists identified at Aligos Therapeutics
Read More
Bristol Myers Squibb patents TLR7/TLR8/TLR9 antagonists
Read More
Environmental support helps blood stem cells cope
Read More
Genethon cleared to begin clinical trial in France with GNT-0004 for Duchenne muscular dystrophy
Read More
OncoMyx presents armed Myxoma virus as potentially promising new oncolytic virotherapy
Read More
Appili initiates new phase III trial of Avigan for treatment of COVID-19
Read More
Phase III ATLANTIS results with Zepzelca and doxorubicin for SCLC
Read More
Tc24-C4.10E shows promise for the treatment of Chagas disease
Read More
CARB-X awards funding to German institutions
Read More
Galapagos begins phase II trial of CFTR inhibitor GLPG-2737 for ADPKD
Read More
reMYND initiates first-in-human trial of ReS19-T for Alzheimer's
Read More
New phase II trial evaluates LYT-100 for long COVID respiratory complications and related sequelae
Read More
FDA approves [68]Ga-PSMA-11 for PET imaging of PSMA-positive lesions in prostate cancer
Read More